Tudor Investment Corp’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,856
| Closed | -$727K | – | 1537 |
|
|
2025
Q1 | $727K | Buy |
+10,856
| New | +$727K | ﹤0.01% | 1118 |
|
|
2020
Q3 | – | Sell |
-6,726
| Closed | -$218K | – | 1252 |
|
|
2020
Q2 | $218K | Sell |
6,726
-9,713
| -59% | -$315K | 0.01% | 989 |
|
|
2020
Q1 | $670K | Buy |
16,439
+9,661
| +143% | +$394K | 0.06% | 373 |
|
|
2019
Q4 | $418K | Sell |
6,778
-521
| -7% | -$32.1K | 0.02% | 768 |
|
|
2019
Q3 | $532K | Buy |
+7,299
| New | +$532K | 0.02% | 687 |
|
|
2017
Q2 | – | Sell |
-8,300
| Closed | -$411K | – | 1012 |
|
|
2017
Q1 | $411K | Buy |
8,300
+3,700
| +80% | +$183K | 0.01% | 793 |
|
|
2016
Q4 | $279K | Sell |
4,600
-1,900
| -29% | -$115K | 0.01% | 1031 |
|
|
2016
Q3 | $431K | Buy |
+6,500
| New | +$431K | 0.01% | 792 |
|
|
2016
Q2 | – | Sell |
-12,431
| Closed | -$418K | – | 1429 |
|
|
2016
Q1 | $418K | Buy |
12,431
+980
| +9% | +$33K | 0.01% | 877 |
|
|
2015
Q4 | $517K | Sell |
11,451
-5,434
| -32% | -$245K | 0.01% | 724 |
|
|
2015
Q3 | $667K | Buy |
16,885
+9,904
| +142% | +$391K | 0.02% | 542 |
|
|
2015
Q2 | $433K | Sell |
6,981
-5,308
| -43% | -$329K | 0.01% | 824 |
|
|
2015
Q1 | $769K | Sell |
12,289
-2,659
| -18% | -$166K | 0.02% | 482 |
|
|
2014
Q4 | $843K | Buy |
+14,948
| New | +$843K | 0.03% | 417 |
|